di Filippo, Luigi http://orcid.org/0009-0002-6117-0081
Ulivieri, Fabio Massimo http://orcid.org/0000-0003-1357-3425
Nuti, Ranuccio http://orcid.org/0000-0003-2380-7432
Giustina, Andrea http://orcid.org/0000-0001-6783-3398
Article History
Received: 29 August 2023
Accepted: 23 September 2023
First Online: 10 October 2023
Compliance with ethical standards
:
: A.G. is consultant for Abiogen Pharma S.p.A. and Takeda and received research grant to Institution from Takeda. The other authors declare no competing interests.